The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study

Guillaume Vial (1) , Noémie Gensous (1) , Hélène Savel (2, 3) , Christophe Richez (4) , Estibaliz Lazaro (4) , Marie-Elise Truchetet (4, 5) , Fabrice Bonnet (2) , Isabelle Pellegrin (2) , Rodolphe Thiébaut (2, 3) , Patrick Blanco (5) , Pierre Duffau (1, 4)

1 Hôpital Saint-André
2 BPH - Bordeaux population health
3 SISTM - Statistics In System biology and Translational Medicine
4 CIRID - Composantes innées de la réponse immunitaire et différenciation
5 Hôpital Pellegrin

Mots clés: IDLIC; SISTM; MORPH3Eus

Domaines: Santé publique et épidémiologie

Guillaume Vial, Noémie Gensous, Hélène Savel, Christophe Richez, Estibaliz Lazaro, et al.. The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot study. Joint Bone Spine, 2020, 88 (2), pp.105097. ⟨10.1016/j.jbspin.2020.105097⟩. ⟨hal-03160699⟩